{"product_id":"harvard-diabetes-comorbidities","title":"Harvard Diabetes Comorbidities and Complications 2023 (Videos)","description":"\u003ch3\u003eHarvard Diabetes Comorbidities and Complications 2023 (Videos)\u003c\/h3\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cbr\u003e\u003cbr\u003eHarvard Diabetes Comorbidities and Complications 2023 Comprehensive Updates for State-of-the-Art Diagnosis, Management, and Prevention \u003cem style=\"color: #333333; font-size: 16px;\"\u003eDiabetes Comorbidities and Complications will be held online, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies. In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations \u003c\/em\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch4\u003eThis comprehensive course provides education and updates to optimize your care of patients with diabetes and these conditions:\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli\u003eObesity\u003c\/li\u003e\n\u003cli\u003eCardiovascular Disease\u003c\/li\u003e\n\u003cli\u003eHeart Failure\u003c\/li\u003e\n\u003cli\u003eCoronary Artery Disease\u003c\/li\u003e\n\u003cli\u003eCerebrovascular Disease\u003c\/li\u003e\n\u003cli\u003eHypertension\u003c\/li\u003e\n\u003cli\u003eHyperglycemia\u003c\/li\u003e\n\u003cli\u003eHypoglycemia\u003c\/li\u003e\n\u003cli\u003eDyslipidemia\u003c\/li\u003e\n\u003cli\u003eMetabolic-Associated Fatty Liver Disease\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eSessions are led by experts in these conditions and their impact on the patient with diabetes. Faculty deliver practical education that is focused on:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAdvancing your knowledge of diabetes comorbidities and complications\u003c\/li\u003e\n\u003cli\u003eDelivering state-of-the-art approaches to evaluation and management of the patient with diabetes and these conditions\u003c\/li\u003e\n\u003cli\u003eIdentifying practical strategies to reduce the risk of diabetes comorbidities and complications\u003c\/li\u003e\n\u003cli\u003eOptimizing clinical decision-making\u003c\/li\u003e\n\u003cli\u003eImproving patient outcomes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eIn addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations to incorporate the vast number of recent updates covered in this program into day-to-day clinical practice.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEDUCATIONAL HIGHLIGHTS\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis program provides strategies, updates, and new practice recommendations to improve your care of patients with (and at risk for) diabetes complications and comorbidities. Participants can rely on this program for updates that ensure state-of-the-art:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003ePREVENTION and RISK REDUCTION\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eDIAGNOSIS\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMANAGEMENT\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eUSE of the NEWEST DIABETES DRUGS, TECHNOLOGIES, and DEVICES \u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003ePREVENTION and RISK REDUCTION\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eNew algorithms for evaluating cardiovascular and renal risk in patients with diabetes\u003c\/li\u003e\n\u003cli\u003eMedical treatment and lifestyle interventions to prevent:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardiovascular disease\u003c\/li\u003e\n\u003cli\u003eKidney disease\u003c\/li\u003e\n\u003cli\u003eCerebrovascular disease\u003c\/li\u003e\n\u003cli\u003eHyper- and hypoglycemia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eMedication interactions: avoiding adverse outcomes\u003c\/li\u003e\n\u003cli\u003eImpact of the newest pharmacological tools to reduce CV and renal disease development and progression\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDIAGNOSIS\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eExpanded options for diagnosis of:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCoronary artery disease\u003c\/li\u003e\n\u003cli\u003eHeart failure\u003c\/li\u003e\n\u003cli\u003eCerebrovascular disease\u003c\/li\u003e\n\u003cli\u003eChronic kidney disease\u003c\/li\u003e\n\u003cli\u003eMetabolic-associated fatty liver disease\u003c\/li\u003e\n\u003cli\u003eHypoglycemia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eMANAGEMENT\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAdjusting pharmacological therapies in the patient with diabetes complications\u003c\/li\u003e\n\u003cli\u003eEvaluating, managing, and monitoring diabetic CKD\u003c\/li\u003e\n\u003cli\u003eObesity management: when to consider new therapeutic and surgical options\u003c\/li\u003e\n\u003cli\u003eDiagnosis and management of coronary artery disease in the patient with diabetes\u003c\/li\u003e\n\u003cli\u003eManagement of kidney disease in the patient with diabetes\u003c\/li\u003e\n\u003cli\u003eHypertension and cholesterol management: customizing targets and treatment strategies for each patient\u003c\/li\u003e\n\u003cli\u003eHeart failure: improving patient functional capacity with combined therapies\u003c\/li\u003e\n\u003cli\u003eManagement of cerebrovascular disease\u003c\/li\u003e\n\u003cli\u003eUpdates in the management of hyper- and hypoglycemia\u003c\/li\u003e\n\u003cli\u003eCurrent guidelines for treating metabolic-associated fatty liver disease\u003c\/li\u003e\n\u003cli\u003eCombining innovative therapeutic combinations with traditional approaches\u003c\/li\u003e\n\u003cli\u003eStrategies to assess and manage interacting comorbidities\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eINCORPORATING NEW DRUGS, TECHNOLOGIES, and DEVICES INTO PRACTICE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe expanded roles of SGLT-2 inhibitors, MRA, and GLP-1 RA in treating CV and renal disease\u003c\/li\u003e\n\u003cli\u003ePractical recommendations for the use of GLP-1 RA, SGLT-2 inhibitors, and MRA\u003c\/li\u003e\n\u003cli\u003eAdvances in glucose monitors, insulin pumps, and diabetes apps\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eSOCIAL, RACIAL, SEXUAL, and CULTURAL DIFFERENCES IN DIABETES CARE NEEDS\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eWe are committed to offering the best practices for health care equity and the needs of diverse patient populations. Highlights include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of diabetes and related disorders in diverse racial\/ethnic populations\u003c\/li\u003e\n\u003cli\u003eRecognizing biases: strategies for achieving equity and addressing disparities\u003c\/li\u003e\n\u003cli\u003eEstablishing and maintaining connections with patients\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003ch5\u003eThis CME program will be held online using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/h5\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003eMonday, July 31, 2023\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch5\u003eWelcome and Introduction\u003c\/h5\u003e\n\u003cbr\u003eA. Enrique Caballero, MD and Romela Petrosyan, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eOBESITY MANAGEMENT\u003c\/h4\u003e\u003cbr\u003eMedical Treatment of Obesity: Updates and Best Practices for Individualizing Therapies\u003cbr\u003eBartolome Burguera, MD\u003cbr\u003e\u003cbr\u003eAdvances in Surgical Treatment of Obesity and Why and When to Refer Patients with Diabetes\u003cbr\u003ePhilip Schauer, MD\u003cbr\u003e\u003cbr\u003eQ \u0026amp; A and Clinical Case Discussion\u003cbr\u003eBartolome Burguera, MD and Philip Schauer, MD\u003cbr\u003e\u003cbr\u003eConcurrent Breakout Sessions\u003cbr\u003e\u003cbr\u003eChoose either of the two breakout sessions listed below\u003cbr\u003eBoth sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.\u003cbr\u003e\u003ch4\u003eCARDIOVASCULAR -\u003c\/h4\u003e\u003cbr\u003eDiagnosis and Management of Heart Failure in the Patient with Diabetes: What Every Physician Now Needs to Know\u003cbr\u003eAkshay Desai, MD\u003cbr\u003e\u003cbr\u003eMETABOLIC - Updates in Continuous Glucose Monitoring and Insulin Pumps in Diabetes Management\u003cbr\u003eDiana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP\u003cbr\u003e\u003cbr\u003eADVANCES in HYPERTENSION MANAGEMENT\u003cbr\u003e\u003cbr\u003eHypertension Management in the Patient with Diabetes: A Practical Approach\u003cbr\u003eNaomi Fisher, MD\u003cbr\u003e\u003cbr\u003eWrap-Up of Day 1\u003cbr\u003eCourse Directors\u003cbr\u003e\u003ch3\u003eTuesday, August 1, 2023\u003c\/h3\u003e\u003cbr\u003eWelcome and Introduction to Day 2 Activities\u003cbr\u003eA. Enrique Caballero, MD and Romela Petrosyan, MD\u003cbr\u003e\u003ch4\u003eUPDATES in DIABETES MANAGEMENT\u003c\/h4\u003e\u003cbr\u003eAdjusting Pharmacological Therapies in the Patient with Diabetes Complications\u003cbr\u003eMarie McDonnell, MD\u003cbr\u003e\u003cbr\u003eUpdates in the Prevention and Management of Hypoglycemia\u003cbr\u003eDevin Steenkamp, MD\u003cbr\u003e\u003cbr\u003eQ \u0026amp; A and Clinical Case Discussion\u003cbr\u003eMarie McDonnell, MD and Devin Steenkamp, MD\u003cbr\u003e\u003ch3\u003eConcurrent Breakout Sessions\u003c\/h3\u003e\u003cbr\u003eChoose either of the two breakout sessions listed below\u003cbr\u003eBoth sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.\u003cbr\u003e\u003cbr\u003eCARDIOVASCULAR - Diagnosis and Management of Coronary Artery Disease in the Patient with Diabetes: Practical Tools for the Busy Clinician\u003cbr\u003eChristopher Cannon, MD\u003cbr\u003e\u003cbr\u003eMETABOLIC - Weight Variability and Diabetes Complications\u003cbr\u003eAntonio Ceriello, MD\u003cbr\u003e\u003ch4\u003eADVANCES in the MANAGEMENT of DYSLIPIDEMIA\u003c\/h4\u003e\u003cbr\u003eUpdates, Innovations, and Advances for the Management of Dyslipidemia in the Patient with Diabetes\u003cbr\u003eOm Ganda, MD\u003cbr\u003eWrap-Up of Day 2\u003cbr\u003eCourse Directors\u003cbr\u003e\u003ch4\u003eWednesday, August 2, 2023\u003c\/h4\u003e\u003cbr\u003eWelcome and Introduction to Day 3 Activities\u003cbr\u003eA. Enrique Caballero, MD and Romela Petrosyan, MD\u003cbr\u003e\u003ch4\u003eUPDATES for CARDIOVASCULAR and RENAL RISK REDUCTION\u003c\/h4\u003e\u003cbr\u003ein the PATIENT with DIABETES\u003cbr\u003ePractical Recommendations for the Use of GLP-1 RA in Clinical Practice and Their Impact on CV and Renal Risk Reduction\u003cbr\u003eVanita Aroda, MD\u003cbr\u003e\u003cbr\u003eKEYNOTE: The Expanded Role of SGLT-2 Inhibitors in Diabetes, Cardiovascular, and Renal Disease: Implications for Clinical Practice\u003cbr\u003eDeepak Bhatt, MD\u003cbr\u003e\u003cbr\u003eKEYNOTE: The Role of MRA Antagonists in CV and Renal Risk Reduction in the Patient with Diabetes: Recent Data and Practical Implications\u003cbr\u003eGeorge Bakris, MD\u003cbr\u003e\u003cbr\u003eQ \u0026amp; A and Clinical Case Discussion\u003cbr\u003eVanita Aroda, MD, Deepak Bhatt, MD, and George Bakris, MD\u003cbr\u003e\u003ch4\u003eConcurrent Breakout Sessions\u003c\/h4\u003e\u003cbr\u003eChoose either of the two breakout sessions listed below\u003cbr\u003eBoth sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.\u003cbr\u003e\u003cbr\u003eCARDIOVASCULAR - Updates in the Evaluation and Management of Peripheral Vascular Disease in the Patient with Diabetes\u003cbr\u003eAllen D. Hamdan, MD\u003cbr\u003e\u003cbr\u003eMETABOLIC - Diabetes in Pregnancy: New Diagnosis and Treatment Guidelines\u003cbr\u003eFlorence Brown, MD\u003cbr\u003e\u003ch4\u003eTHE EDWARD S. HORTON LECTURE\u003c\/h4\u003e\u003cbr\u003eManagement of Diabetes and Related Disorders in Diverse Racial\/Ethnic Populations\u003cbr\u003eA. Enrique Caballero, MD\u003cbr\u003e\u003cbr\u003eWrap-Up of Day 3\u003cbr\u003eCourse Directors\u003cbr\u003e\u003ch3\u003eThursday, August 3, 2023\u003c\/h3\u003e\u003cbr\u003eWelcome and Introduction to Day 4 Activities\u003cbr\u003eA. Enrique Caballero, MD and Romela Petrosyan, MD\u003cbr\u003e\u003ch4\u003eCHRONIC KIDNEY DISEASE\u003c\/h4\u003e\u003cbr\u003ein the PATIENT with DIABETES\u003cbr\u003eEvaluation and Monitoring of Diabetic CKD\u003cbr\u003eRomela Petrosyan, MD\u003cbr\u003eKEYNOTE: Current Clinical Guidelines for the Management of CKD in Diabetes\u003cbr\u003eKatherine R. Tuttle, MD, FASN, FACP, FNKF\u003cbr\u003e\u003cbr\u003eQ \u0026amp; A and Clinical Case Discussion\u003cbr\u003eRomela Petrosyan, MD and Katherine R. Tuttle, MD, FASN, FACP, FNKF\u003cbr\u003e\u003ch4\u003eConcurrent Breakout Sessions\u003c\/h4\u003e\u003cbr\u003eChoose either of the two breakout sessions listed below\u003cbr\u003eBoth sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.\u003cbr\u003e\u003cbr\u003eCARDIOVASCULAR - Evaluation and Management of Sexual Dysfunction in Patients with Diabetes\u003cbr\u003eMartin N. Kathrins, MD\u003cbr\u003e\u003cbr\u003eMETABOLIC - Updates and Best Practices for State-of-the-Art Insulin Therapy\u003cbr\u003eGuillermo Umpierrez, MD\u003cbr\u003e\u003ch4\u003eADVANCES in NON-ALCOHOLIC FATTY LIVER DISEASE\u003c\/h4\u003e\u003cbr\u003eDiagnosis and Management of Non-Alcoholic Fatty Liver Disease\u003cbr\u003eKen Cusi, MD\u003cbr\u003e\u003cbr\u003eClosing Remarks\u003cbr\u003eCourse Directors","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954293805154,"sku":"MED-AMB00493","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Diabetes-Comorbidities-and-Complications-2023.webp?v=1779370315","url":"https:\/\/meducourse.com\/products\/harvard-diabetes-comorbidities","provider":"Meducourse","version":"1.0","type":"link"}